Showing 117 of 117on this page. Filters & sort apply to loaded results; URL updates for sharing.117 of 117 on this page
Spleen SORT LNP Generated in situ CAR T Cells Extend Survival in a ...
mRNA in vitro Transcription and LNP for protein, Antibody and CAR ...
Exploring Innovative LNP Technology and mRNA Approaches for In Vivo CAR ...
Lipid nanoparticles outperform electroporation in mRNA-based CAR T cell ...
Strategies for Altering Delivery Technologies to Optimize CAR Therapy
Lipid nanoparticles for engineering next generation CAR T cell ...
mRNA‐LNP‐assisted CAR cell production. A) Schematic illustration of CAR ...
Targeted delivery of nanoparticles for in vivo CAR T therapy
Delivery of plasmid DNA by LNPs to induce CAR in T cells | IJN
Accelerating CAR T Cell Therapy: Lipid Nanoparticles Speed Up ...
CAR Macrophages Engineered In Vivo for Attenuating Myocardial Ischemia ...
CAR T Cell Therapy with a Scalable RNA Lipid Nanoparticle Platform ...
Webinar: LNP Approaches for in vivo CAR-T Therapy: From Science to ...
Precision medicine: In vivo CAR therapy as a showcase for receptor ...
First in vivo CAR gene therapy trial in Europe approved - European ...
Optimal Chimeric Antigen Receptor (CAR)-mRNA for Transient CAR T Cell ...
Ionizable Lipid Nanoparticle-Mediated mRNA Delivery for Human CAR T ...
Direct in vivo CAR T cell engineering: Trends in Pharmacological Sciences
CAR mRNA-LNP transfection to expanded NK cells results in high ...
Frontiers | Engineering strategies to safely drive CAR T-cells into the ...
New Approaches for LNP Design and Microfluidic Manufacturing for ...
Anti-CD19 CAR mRNA-LNP - PM-LNP-0016 - Products | ProMab
Overview of the LNP formulation and delivery in vitro and in vivo. (a ...
Can CAR T Therapy Be Delivered By Direct Injection? – ACCESS
CAR T cells produced in vivo to treat cardiac injury | Science
Lentiviral transduction, CAR expression, expansion, and killing ...
De-Risking LNP & RNA-Based In Vivo CAR-T Therapies - Accelevir
Transposon-Based CAR T Cells in Acute Leukemias: Where Are We Going?
CAR-encoded mRNA-LNP delivery system. a Schematic representation of ...
未来已来！Capstan首次公布基于抗体偶联LNP的In vivo CAR-T NHP数据医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
LNP共递送mRNA和siRNA→PD1lo CAR-T细胞|siRNA|PD1lo|mRNA|EGFP|-健康界
抗体修饰LNPs靶向递送mRNA体内生成CAR-T细胞 - 知乎
Capstan公布in vivo CAR-T疗法非人灵长类动物试验最新数据 - 星辉看世界 - Xinhui Times
Progress in nanoparticle-based regulation of immune cells
The use of targeted LNP/mRNA technology to generate functional ...
卷土重来：in vivo CAR-T的研发进展与挑战 - 知乎
LNP递送双mRNA原位生成CAR-Ms治疗肝癌，揭示LNP蛋白冠对细胞摄取的影响 - 知乎
(PDF) Treatment of cardiac fibrosis: from neuro-hormonal inhibitors to ...
In Vivo Engineered CAR-T Cell Therapy: Lessons Built from COVID-19 mRNA ...
mRNA-LNP在新一代CAR-T细胞疗法中的作用_生物器材网
CAR疗法双革命：从in vivo突破，到circRNA+LNP开启 “持久表达”新赛道
Angewandte Chemie International Edition: Vol 62, No 44
环码联合北大团队基于新型LNP和circRNA靶向脾脏和T细胞表达开发体内CAR-T疗法，促进炎症性衰老治疗医药新闻-ByDrug-一站式医药 ...
In vivo CAR-T: mRNA-LNP Driven Technological Breakthroughs and Clinical ...
CAR-NK Cells Generated with mRNA-LNPs Kill Tumor Target Cells In Vitro ...
停药后有望长期缓解！《自然》子刊：这些自身免疫性疾病患者，更适合CAR-T疗法-MedSci.cn
In Vivo CAR-T Therapy with Lipid Nanoparticles: A Non-Viral Approach
Harnessing nanoengineered CAR-T cell strategies to advance solid tumor ...
解析：脂质纳米颗粒（LNP）的设计流程及制备
T cell-specific non-viral DNA delivery and in vivo CAR-T generation ...
PUBLICATIONS – MITCHELL LAB
In Vivo CAR-T and Targeted mRNA Delivery: From Research to Early ...
In vivo production of CAR-T cells using CD5/LNP-FAPCAR. Administration ...
Full article: Nanomaterials Mediated Enhancement of CAR-T for HCC ...
用于 CAR-T 治疗的 mRNA-LNP 技术的关键考虑因素：成分、有效负载和新兴前景,Materials Chemistry ...
全面认识LNP递送mRNA用于治疗癌症
mRNA LNP疗法：这才哪跟哪儿？ - 知乎
重磅突破！迈安纳客户采用LNP技术实现多重RNA递送，精准编辑CAR-T细胞抗癌效果显著提升 - 知乎
UPenn Researchers Engineer Immune Cells that Restore Heart Function
Frontiers | Straight to the point: targeted mRNA-delivery to immune ...
Targeted in vivo delivery of genetic medicines utilizing an engineered ...
mRNA Strategies for Cancer Immunotherapy – BOC Sciences
技术前沿 | 远泰生物mRNA-LNP技术应用策略一览
Frontiers | In-Vivo Induced CAR-T Cell for the Potential Breakthrough ...
In Vivo CAR-T疗法新突破：Ab-LNP引领免疫治疗新纪元 - 知乎
CAR-T & CAR-NK - uBriGene
运用LNP进行基因敲入！In vivo CAR-T的全新技术路线医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
CRISPR Tx 2026 JPM上的数据披露：“抗体-LNP”偶联平台与In Vivo CAR-T数据
CAR-T therapy dilemma and innovative design strategies for next ...
新一代CAR-T细胞疗法的突破性进展与临床应用前景-MedSci.cn
BAFFR CAR-NK Cells - PeproMene Bio IncPeproMene Bio Inc
脂质纳米颗粒(LNP)在肿瘤免疫治疗中的应用 - 知乎
LNP递送mRNA在体内生成CAR-T，新锐公司再获1.75亿美元融资，推进自身免疫病CAR-T临床研究医药新闻-ByDrug-一站式医药资源 ...
Preclinical proof of concept for VivoVec, a lentiviral-based platform ...
Advancing RNA
Lipid nanoparticle (LNP) mediated mRNA delivery in cardiovascular ...
In-vivo CAR-T(体内 CAR-T)细胞疗法的全球格局、优势及面临的挑战_生物器材网
【Science】利用靶向LNP在体内构建功能性CAR-T细胞用于癌症与自身免疫疾病的治疗 - Book学术
Engineered nanoparticles for in vivo CAR-T cell production. The top ...
Nature & Cell, 揭示CAR-T开发新思路 - 知乎
Frontiers | Cytokines as an important player in the context of CAR-T ...
优卡迪：新型LNP体内靶向制备CAR-T，抗肿瘤效果显著 - 知乎
自主研发LNP+mRNA技术平台，深信生物布局新型体内CAR-T疗法医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
T细胞靶向LNP通过递送DNA体内制备CAR-T - 知乎
CAR-T Cell Therapy: From the Shop to Cancer Therapy
高分综述|体内CAR细胞疗法：mRNA-LNP与病毒载体 - 知乎
Frontiers | mRNA vaccines for cancer immunotherapy
Cardiolipin-mimic lipid nanoparticles without antibody modification ...
Bioact Mater：利用涂覆CAR-T细胞膜的纳米颗粒将化疗药物靶向递送到癌细胞_生物科技_健康一线资讯
